- Vaccine experts are excited about mRNA’s success in COVID, but it’s not time to ‘walk away’ from traditional shots: panel (fiercepharma.com)
The COVID-19 pandemic has raised the profile of mRNA vaccines in a dramatic way in about a year. Looking forward, the technology holds more promise and could displace traditional shots in some diseases, experts said, but it's not time to give up on well-known vaccine platforms, either...researchers at Moderna...reached human testing for their mRNA vaccine in record time. And separately, in under a year of development, testing and manufacturing, Pfizer and its mRNA partner BioNTech were able to score an FDA emergency use authorization last December...In addition to being able to rapidly advance new vaccines in response to emerging threats, the “beauty” of the platform is that the production process is “universal,"...Still, it’s not time to go all-in on mRNA... While experts are clearly enthusiastic about the platform, that “doesn’t guarantee that mRNA will immediately work against all pathogens,"...READ MORE
- Washoe County received doses from Moderna vaccine lot in question in California, though no allergic reactions reported (thenevadaindependent.com)
Washoe County Health District received doses from the same lot of Moderna’s coronavirus vaccine that California health officials have recommended providers stop administering after several people in the state experienced apparent severe allergic reactions...The health district administered doses from the same lot Moderna’s COVID-19 vaccine, 041L20A, to about 770 people at its drive-thru point of dispensing vaccination site...None of those individuals have reported severe allergic reactions, and there were no issues reported from patients who used the 15- and 30-minute waiting lots, which are set up to ensure that patients don’t experience any allergic reactions before driving off, after receiving the vaccine...READ MORE
- FDA Publishes COVID-19 Pandemic Recovery and Preparedness Plan Summary Report (biopharminternational.com)FDA COVID-19 Pandemic Recovery and Preparedness Plan (PREPP) Initiative: Summary ReportJanuary 2021 (fda.gov)
A report on the FDA PREPP initiative’s work in 2020 aims to strengthen the Agency’s response to future public health emergencies...FDA announced on Jan. 13, 2021 that it had published a report summarizing the work to date of the COVID-19 Pandemic Recovery and Preparedness Plan (PREPP) initiative, which was launched in August 2020 to strengthen the Agency’s response to the current pandemic and to future public health emergencies...FDA asked an independent, non-government organization to review its pandemic response, record its accomplishments and activities, and pinpoint future opportunities for consideration, an FDA press release said. The organization interviewed FDA leaders, organized listening sessions with external stakeholder groups, and partnered with subject matter experts on the FDA staff to generate a summary report...READ MORE
- Health fraud case: Mississippi pharmacy owner gets 18 years (msn.com)Wade Walters sentenced to 18 years for role in medical insurance fraud scheme (wlox.com)
A Mississippi owner of pharmacies and pharmacy distributors has been sentenced to 18 years in prison and ordered to repay the government nearly $287.7 million for his part in what prosecutors described as a $510 million health care fraud involving high-priced pain cream...Wade Ashley Walters...of Hattiesburg, also was ordered...to forfeit nearly $56.6 million that he gained personally from the scheme...Walters had been charged in a 37-count indictment. He pleaded guilty in July to one count each of conspiracy to commit health care fraud and conspiracy to commit money laundering...Between 2012 and 2016, Walters orchestrated a scheme to defraud Tricare, the insurance program for U.S. military, veterans, and their families, and private health insurers by distributing compounded medications that were not needed...READ MORE
- Biden unveils national strategy that Trump resisted (pharmacist.com)
Unlike his predecessor, President Biden is embracing a more centralized strategy for managing the COVID-19 pandemic. He signed a flurry of executive orders and presidential directives on January 21, including one that institutes new mask mandates for interstate travel, one that creates a national board to expand access to testing, and another that requires international visitors to quarantine upon arrival in the United States. Biden pitched his National Strategy for the COVID-19 Response and Pandemic Preparedness as a "wartime effort" and did not soft-pedal the grim details...READ MORE
- Biden’s COVID-19 challenge: 100M vaccinations in the first 100 days. It won’t be easy (fiercehealthcare.com)
...during a once-in-a-century pandemic, incoming President Joe Biden has promised to provide 100 million COVID-19 vaccinations in his first 100 days in office...“This team will help get …at least 100 million COVID vaccine shots into the arms of the American people in the first 100 days,” Biden said...When first asked about his pledge, the Biden team said the president-elect meant 50 million people would get their two-dose regimen. The incoming administration has since updated this plan, saying it will release vaccine doses as soon as they’re available instead of holding back some of that supply for second doses...Either way, Biden may run into difficulty meeting that 100 million mark...READ MORE
- Vaccine Rollout Even Worse than Expected (biopharminternational.com)Operation Warp Speed Announces Changes to COVID-19 Vaccine Distribution Strategy (drugtopics.com)
Although there was much analysis and anticipation over the past year about the difficulties and challenges in distributing millions of doses of new vaccines across the nation, the process so far has been much less effective than anticipated...30 million doses have been distributed, but only 4 million people were vaccinated in December 2020, and just 13 million have received shots so far...A main problem was the administration’s delay in authorizing the Centers for Disease Control and Prevention to provide states with clear guidelines for updating existing local procedures for distributing vaccines that critical “last mile” to clinics and health centers... Uncertainty about vaccine shipments and supplies, at a time when hospitals were dealing with surges in COVID-19 infections and deaths, prompted medical centers to cancel in-house vaccination activities. And there still is confusion about whether clinics should hold back supplies for second doses or administer all on hand...READ MORE
- Las Vegas man charged in $2M federal virus relief fraud case (apnews.com)Las Vegas man charged with fraud in obtaining $2M in PPP funds (reviewjournal.com)
A Nevada man has been charged with fraudulently obtaining about $2 million in federal coronavirus relief aid, meant for small businesses, to buy luxury vehicles and condominiums in Las Vegas...The U.S. attorney’s office in Nevada accused Jorge Abramovs with bank fraud after he allegedly applied for funding to at least seven banks between April and June 2020...The complaint said Abramovs used a variety of company names — National Investment Group Corporation, National Legal Advisors In Care Of and National Investment Group — that “misrepresented the number of employees and the amount of revenue and payroll his companies had” to the banks...READ MORE
- Here are the top healthcare items in Biden’s proposed $1.9T COVID-19 relief plan (fiercehealthcare.com)
President-elect Joe Biden’s new $1.9 trillion COVID-19 relief plan includes money for boosting subsidies to help pay down the costs of Affordable Care Act exchange plans, bolstering supplies and for vaccine distribution...The American Relief Plan...includes new investments in supplies for strapped hospitals, money for vaccines and testing and seeks to give front-line healthcare workers new federal protections...A key pillar of the plan is $20 billion for a national vaccine program that partners with state and local governments. The plan will launch community vaccination centers around the country and mobile units for any hard-to-reach areas...READ MORE
- Woodcock to step up to interim FDA chief as she and Sharfstein are vetted for permanent job: reports (fiercepharma.com)
FDA veteran Janet Woodcock will take over as commissioner, at least temporarily, according to media reports, and former deputy FDA chief Joshua Sharfstein is at the top of the list for the permanent job...President-elect Joseph Biden has tapped Woodcock as interim FDA commissioner while his team searches for a permanent replacement...Woodcock now oversees COVID-19 therapy development as part of Operation Warp Speed and has headed up the Center for Drug Evaluation and Research since 2008...READ MORE









